e-SPACE Heart Failure 2024

  • Published:  28 October 2024
  • Likes: 

    Heart Icon

    0

Up Next

e-SPACE Heart Failure 2024

  • Published:  28 October 2024
  • Likes: 

    Heart Icon

    0

Average (ratings)
No ratings
Your rating
Overview

Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure held on the 18-19 October 2024.

 

e-SPACE Heart Failure 2024 once again provided top-tier free virtual education and optimised geographical reach whilst delivering both global and regional insight. The thoughtfully curated programme explored how leading experts are incorporating heart failure guidelines into clinical practice and offered the latest information on patient profiling in heart failure for tailored medical therapy.

 

Building on the tremendous success of previous years, this event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.

 

Related sessions to e-SPACE Heart Failure 2024:

e-SPACE Heart Failure 2024 would like to thank the following sponsors:

Learning Objectives

  • Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
  • Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
  • Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
  • Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
  • Translate the findings of recent studies and guidelines into optimal patient management

Target Audience

  • Heart Failure Specialists
  • General Cardiologists
  • General Practitioners (GPs)
  • Nurses, Pharmacists, and other Allied Healthcare Professionals

More from this programme

Faculty Biographies

John J Atherton

John J Atherton

Director of Cardiology

Dr John J. Atherton is a Sydney-born Australian cardiologist and clinician-scientist who has built his professional life in Brisbane, Queensland, where he currently serves as Director of Cardiology at the Royal Brisbane and Women’s Hospital. He practices adult cardiology with a focus on heart failure and advanced cardiovascular disease, and lives in Brisbane while maintaining academic appointments across multiple universities in Queensland.

 

Academic History

Dr Atherton earned his medical degree (MBBS) in Australia and completed specialist training in cardiology, achieving membership of the Royal Australasian College of Physicians (FRACP) and advanced fellowships in cardiology. His academic roles include Professor in the Faculty of Medicine at the University of Queensland and Adjunct Professor in the Faculty of Health at the Queensland University of Technology.

He completed a PhD focused on symptom interventions and self-management in chronic cardiac…

View full profile
Tarek Bekfani

Tarek Bekfani

Consultant Cardiologist

Dr Tarek Bekfani is a Consultant Cardiologist at University hospital Magdeburg A.o.R., Magdeburg, DE.

View full profile
Javed Butler

Javed Butler

Professor of Medicine

Dr Javed Butler is President, Baylor Scott and White Research Institute, Senior Vice President for the Baylor Scott and White Health and Professor of Medicine at the University of Mississippi, US. He is board certified in cardiovascular medicine and advanced heart failure and transplant medicine. His research interests focus on clinical trials in patients with heart failure.

He serves on several national committees for the American College of Cardiology, American Heart Association, National Institutes of Health, and the Heart Failure Society of America. He is the recipient of the Simon Dack Award by the American College of Cardiology as well as the Time, Feeling, and Focus Award by the American Heart Association.

Prof Butler has authored more than 900 peer-reviewed publications. He serves on the editorial board of several peer reviewed cardiovascular journals and has been cited numerous times in America’s Best Doctors list.

 

View full profile
Clara Saldarriaga

Clara Saldarriaga

Professor of Cardiology

Prof Clara Saldarriaga is an Editorial Board member of Cardiac Failure Review and may be contacted here.

Academic History

Prof Saldarriaga completed her undergraduate studies in Medicine at the Jesus Maria School in Medellin in 1994 and went on to continue her studies at the Medical School at the University of Antioquia in 2002. She then went on to complete her Internal Medicine Residency at the University of Antioquia in 2008.

Career Overview

Prof Saldarriaga is currently a Professor of Cardiology at Cardiovascular Clinic Santa Maria at the University of Antioquia in Medellín. She is a member of the American College of Physicians and the Columbian Association of internal medicine.

Prof Clara Saldarriaga is also President of the Columbian Society of Cardiology – she…

View full profile
Faiez Zannad

Faiez Zannad

Professor Emeritus; Founder and Chairman of CVCT Société Civile

Prof Faiez Zannad was born in Monastir, Tunisia in 1951 and later moved to pursue his medical education and research in Europe. He trained in cardiology and pharmacology across institutions in France and the United Kingdom, including Nancy, Lyon, and Oxford. Over the course of his career, he has lived and worked primarily in Nancy, France, where he has held clinical, academic, and research leadership roles in cardiovascular medicine and therapeutics.

 

Academic History

Prof Zannad earned his MD in cardiology from the Faculté de Médecine de Nancy and further trained as a research fellow in clinical pharmacology at the Medical Research Council in Oxford. He later received a PhD in cardiovascular clinical pharmacology from the University of Lyon. During his academic training, he focused on cardiovascular pharmacology, physiology, and therapeutic innovation, laying the foundation for his lifelong work in heart failure and hypertension research.

Following…

View full profile